Product News: Alpha Laboratories Launches New Website Dedicated to Calprotectin Testing

01 May 2013 is a new website that is dedicated to raising awareness amongst Clinicians and Laboratories about the value of testing for Calprotectin.

Faecal Calprotectin is a new biomarker which is helping to save money for the NHS by preventing unnecessary procedures on patients by screening out those with IBS who do not therefore require endoscopies.

The symptoms of functional disorders such as Irritable Bowel Syndrome (IBS) and organic inflammatory intestinal disease (IBD) can be very similar in presentation but are two very different medical conditions. Historically, clinical gastroenterologists have had to use invasive endoscopy to differentially diagnose between these conditions. Not only is this stressful for the patient, it is costly for the NHS.

The NHS Centre for Evidence-based Purchasing has conducted several reviews on calprotectin testing and its use in differentiating IBS and IBD. These reports conclude that using calprotectin assays supports improvements in patient management as well as offering substantial cost savings. also introduces CALcheck Blue™, the latest product from the Buhlmann Calprotectin Test Family. It is a dipstick immunoassay designed for the qualitative determination of calprotectin in human stool samples. It is intended for screening for organic intestinal bowel diseases (IBD). CALcheck Blue™ comes in two different formats for the laboratory, Gastroenterology clinic and primary care environments.